Jidong Cheng

853 total citations
31 papers, 702 citations indexed

About

Jidong Cheng is a scholar working on Molecular Biology, Pharmacology and Nephrology. According to data from OpenAlex, Jidong Cheng has authored 31 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pharmacology and 5 papers in Nephrology. Recurrent topics in Jidong Cheng's work include Inflammatory mediators and NSAID effects (7 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Jidong Cheng is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). Jidong Cheng collaborates with scholars based in Japan, China and United States. Jidong Cheng's co-authors include Hiroyasu Imanishi, Toshikazu Hada, Weidong Liu, Xubin Jing, Noboru Ueki, Takayuki Morisaki, Hideji Nakamura, Yoshiki Amuro, Toshikazu Hada and Hiroko Morisaki and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Hepatology and International Journal of Cancer.

In The Last Decade

Jidong Cheng

31 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jidong Cheng Japan 14 280 155 128 93 83 31 702
Rachel J. Church United States 18 180 0.6× 98 0.6× 128 1.0× 86 0.9× 68 0.8× 21 685
Qiaoke Gong United States 16 294 1.1× 65 0.4× 74 0.6× 79 0.8× 30 0.4× 26 918
Ting Jiang China 13 271 1.0× 64 0.4× 94 0.7× 84 0.9× 29 0.3× 30 673
Guofeng Wang China 16 275 1.0× 70 0.5× 136 1.1× 60 0.6× 50 0.6× 42 924
Tamás Kardon Hungary 17 386 1.4× 42 0.3× 105 0.8× 135 1.5× 39 0.5× 30 926
Anding Liu China 20 296 1.1× 114 0.7× 312 2.4× 68 0.7× 101 1.2× 34 882
Yoichi Yasuda Japan 13 305 1.1× 52 0.3× 168 1.3× 167 1.8× 47 0.6× 18 748
M. Ribecco Italy 14 243 0.9× 81 0.5× 218 1.7× 23 0.2× 50 0.6× 22 745
Dujuan Xu China 16 354 1.3× 71 0.5× 63 0.5× 93 1.0× 36 0.4× 33 661

Countries citing papers authored by Jidong Cheng

Since Specialization
Citations

This map shows the geographic impact of Jidong Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jidong Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jidong Cheng more than expected).

Fields of papers citing papers by Jidong Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jidong Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jidong Cheng. The network helps show where Jidong Cheng may publish in the future.

Co-authorship network of co-authors of Jidong Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Jidong Cheng. A scholar is included among the top collaborators of Jidong Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jidong Cheng. Jidong Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Qiang, Hairong Zhao, Wei Yu, et al.. (2022). Receptor of Advanced Glycation End Products Deficiency Attenuates Cisplatin-Induced Acute Nephrotoxicity by Inhibiting Apoptosis, Inflammation and Restoring Fatty Acid Oxidation. Frontiers in Pharmacology. 13. 907133–907133. 6 indexed citations
2.
Hu, Lidong, Xiaojian Ji, Yiwen Wang, et al.. (2021). Underweight and obesity are strong predictors of clinical outcomes in patients with ankylosing spondylitis: data from the Smart-phone SpondyloArthritis Management System. Therapeutic Advances in Musculoskeletal Disease. 13. 1759720X211030792–1759720X211030792. 6 indexed citations
3.
Hu, Lidong, et al.. (2020). Tai Chi exercise can ameliorate physical and mental health of patients with knee osteoarthritis: systematic review and meta-analysis. Clinical Rehabilitation. 35(1). 64–79. 48 indexed citations
4.
Yu, Wei, et al.. (2020). The Role and Molecular Mechanism of FoxO1 in Mediating Cardiac Hypertrophy. ESC Heart Failure. 7(6). 3497–3504. 32 indexed citations
5.
Hirase, Tetsuaki, et al.. (2017). Role of AMPD2 in impaired glucose tolerance induced by high fructose diet. Molecular Genetics and Metabolism Reports. 13. 23–29. 14 indexed citations
6.
Cheng, Jidong, Hiroko Morisaki, N. Sugimoto, et al.. (2014). Effect of isolated AMP deaminase deficiency on skeletal muscle function. Molecular Genetics and Metabolism Reports. 1. 51–59. 15 indexed citations
7.
8.
Cheng, Jidong, Hiroko Morisaki, Keiko Toyama, et al.. (2012). AMPD3‐deficient mice exhibit increased erythrocyte ATP levels but anemia not improved due to PK deficiency. Genes to Cells. 17(11). 913–922. 12 indexed citations
9.
Liu, Weidong, Hideji Nakamura, Tohru Tsujimura, et al.. (2006). Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase‐2 inhibitor. Cancer Science. 97(8). 768–773. 13 indexed citations
10.
11.
Cheng, Jidong, Hideji Nakamura, Hiroyasu Imanishi, et al.. (2004). Peroxisome proliferator-activated receptor γ ligands, 15-deoxy-Δ12,14-prostaglandin J2, and ciglitazone, induce growth inhibition and cell cycle arrest in hepatic oval cells. Biochemical and Biophysical Research Communications. 322(2). 458–464. 14 indexed citations
12.
Inokuchi, Taku, Yuji Moriwaki, Sumio Takahashi, et al.. (2004). Identification of a new point mutation in hypoxanthine phosphoribosyl transferase responsible for hyperuricemia in a female patient. Metabolism. 53(11). 1500–1502. 7 indexed citations
13.
Yamamoto, Tetsuya, Yuji Moriwaki, Sumio Takahashi, et al.. (2004). Effect of sauna bathing and beer ingestion on plasma concentrations of purine bases. Metabolism. 53(6). 772–776. 8 indexed citations
14.
Yamamoto, Tetsuya, Yuji Moriwaki, Sumio Takahashi, et al.. (2003). Identification of a new point mutation in the human molybdenum cofactor sulferase gene that is responsible for xanthinuria type II. Metabolism. 52(11). 1501–1504. 24 indexed citations
15.
Jing, Xubin, Noboru Ueki, Jidong Cheng, Hiroyasu Imanishi, & Toshikazu Hada. (2002). Induction of Apoptosis in Hepatocellular Carcinoma Cell Lines by Emodin. Japanese Journal of Cancer Research. 93(8). 874–882. 85 indexed citations
16.
Yamamoto, Tetsuya, Yuji Moriwaki, Jidong Cheng, et al.. (2002). Effect of inosine on the plasma concentration of uridine and purine bases. Metabolism. 51(4). 438–442. 11 indexed citations
17.
Cheng, Jidong, Hiroyasu Imanishi, Yoshiki Amuro, & Toshikazu Hada. (2002). NS‐398, a selective cyclooxygenase 2 inhibitor, inhibited cell growth and induced cell cycle arrest in human hepatocellular carcinoma cell lines. International Journal of Cancer. 99(5). 755–761. 66 indexed citations
18.
Liu, Weidong, Jidong Cheng, Arata Iwasaki, Hiroyasu Imanishi, & Toshikazu Hada. (2002). Novel mutation and multiple mutations found in the human butyrylcholinesterase gene. Clinica Chimica Acta. 326(1-2). 193–199. 10 indexed citations
19.
20.
Liu, Weidong, Toshikazu Hada, Jidong Cheng, & Kazuya Higashino. (2000). Point mutations in E2, NS3 and NS5A of hepatitis G virus. World Journal of Gastroenterology. 6. 69–69. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel J. Church Breakdown of academic impact, for papers by Qiaoke Gong Breakdown of academic impact, for papers by Ting Jiang Breakdown of academic impact, for papers by Guofeng Wang Breakdown of academic impact, for papers by Tamás Kardon Breakdown of academic impact, for papers by Anding Liu Breakdown of academic impact, for papers by Yoichi Yasuda Breakdown of academic impact, for papers by M. Ribecco Breakdown of academic impact, for papers by Dujuan Xu
Rankless by CCL
2026